肿瘤细胞治疗研究
英文原题：New T-Cell Therapies for Brain Metastasis, CD133 in the Driver's Seat.
New T-Cell Therapies for Brain Metastasis, CD133 in the Driver's Seat.
嵌合抗原受体（CAR）T 细胞免疫疗法已彻底改变了一些晚期癌症的治疗，但其成功取决于能否确定正确的细胞表面靶点。
嵌合抗原受体（CAR）T细胞免疫疗法已革新部分晚期癌症治疗，但成功的前提是找到正确的细胞表面靶点。在一篇近期发表的文章中，作者利用癌症干细胞表面抗原CD133开发CAR-T疗法治疗脑转移瘤。参见Kieliszek等人的相关文章，第554页。
Chimeric antigen receptor (CAR)-T cell immunotherapy has revolutionized cancer therapy for some advanced cancers, but success is predicated on identifying the correct cell surface target. In a recent article, the authors leveraged the cancer stem cell surface antigen CD133 to develop a CAR-T therapy for brain metastasis. See related article by Kieliszek et al., p. 554.
MEMBER ACCOUNT
登录成功会直接打开下一页。
